Left ventricular ejection fraction and mortality in patients with ST-elevation myocardial infarction and bundle

M Yldau van der Ende1, Minke H T Hartman, Tom Hendriks

  • 1Department of Cardiology, University Medical Center Groningen, University of Groningen, Groningen, the Netherlands.

Coronary Artery Disease
|December 2, 2016
PubMed

Insights

Bundle branch block (BBB) independently predicts reduced left ventricular ejection fraction (LVEF) in ST-elevation myocardial infarction (STEMI) patients. However, BBB did not impact 2-year mortality in the current era of reperfusion therapy.

Area of Science:

  • Cardiology
  • Cardiovascular Medicine
  • Interventional Cardiology

Background:

  • Bundle branch block (BBB) is a known complication of ST-elevation myocardial infarction (STEMI).
  • The impact of BBB on outcomes in STEMI patients treated with modern reperfusion therapies remains an area of investigation.

Purpose of the Study:

  • To evaluate the effect of BBB on mortality and left ventricular ejection fraction (LVEF) in STEMI patients receiving percutaneous reperfusion therapy.
  • To determine if BBB is an independent predictor of adverse outcomes in this patient population.

Main Methods:

  • Retrospective cohort study of 1123 STEMI patients treated between January 2011 and May 2013.
  • Follow-up duration of 2-4 years with transthoracic echocardiography performed within 2 weeks post-STEMI.

Main Results:

  • 2.0% of patients presented with left BBB and 4.4% with right BBB.
  • Two-year mortality was 25.0% in patients with BBB versus 9.2% in those without (P<0.001).
  • BBB was associated with a higher incidence of severely reduced LVEF (<30%) and lower incidence of normal LVEF.

Conclusions:

  • Bundle branch block is an independent predictor of reduced LVEF in STEMI patients.
  • BBB did not emerge as an independent predictor of 2-year mortality in the current era of percutaneous reperfusion therapy.
Abstract

Related Concept Videos

Mitral Stenosis I: Introduction01:22

Mitral Stenosis I: Introduction

Mitral Valve Stenosis (MVS) is a heart condition where the mitral valve narrows, impeding blood circulation from the left atrium to the left ventricle. The etiology and pathophysiology of this condition are multifaceted, leading to a cascade of cardiovascular complications.Causes of Mitral Valve StenosisRheumatic Heart Disease: It is the main cause of mitral valve stenosis, particularly in developing nations. This condition arises from rheumatic fever, an inflammatory illness resulting from...
1.0K
Mitral Stenosis II: Clinical features and Diagnostic Tests01:23

Mitral Stenosis II: Clinical features and Diagnostic Tests

Mitral stenosis is a heart condition in which the mitral valve, which allows blood to flow from the left atrium to the left ventricle, becomes narrowed or stenotic. This narrowing hinders blood flow and leads to clinical symptoms requiring specific medical evaluations and management strategies. The following overview outlines the clinical symptoms, assessments, diagnostic findings, prevention methods, and treatments for mitral stenosis.Clinical ManifestationsDyspnea (shortness of breath): This...
374
Heart Failure IV: Classification and Diagnostic Evaluation01:30

Heart Failure IV: Classification and Diagnostic Evaluation

Heart failure can be classified in various ways, with the most common classifications based on physical activity limitations, disease progression, severity, and treatment strategies.The Functional Classification of Heart Failure divides patients into four categories based on physical activity limitation due to symptom burden.Class I: Patients in this class have cardiac disease but no physical activity limitations. Ordinary activities like walking, climbing stairs, or routine tasks do not cause...
510